Amarin Corp Plc (AMRN)

[Ajax133]

Kiwi: Excellent point but a bit overstated. The PCSK9
drugs will be facing large discounts from the PBM's,
just as we are witnessing in Hepatitis C between GILD
and ABBV. They are so far superior to Statins, that
when I say 'all" I'm really referring to a continuous
erosion in sales from the Private Sector. Managed Care
and the ACA will only reimburse and dispense the cheap
generic Statins, until the ACC/AHA take a decisive stand.
Their efficacy data and safety profile are most compelling.
The average lowering of LDL C is about 70%. There are
numerous players, AMGN, REGN,SNY, PFE etc. this IMO will
set off the mother of all price wars. Stay tuned.